Table 2 Descriptive statistics for the GLASS cohort according to recurrence outcome and tumor grade
From: A deep learning model to predict glioma recurrence using integrated genomic and clinical data
|  | Late glioma recurrence (TTR ≥ 390 days) | Early glioma recurrence (TTR < 390 days) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Tumor grade (n) | All (43) | II (6) | III (7) | IV (30) | All (58) | II (0) | III (2) | IV (56) | |
Sex [n] | Male | 25 | 3 | 6 | 16 | 41 | 0 | 1 | 40 |
Female | 18 | 3 | 1 | 14 | 17 | 0 | 1 | 16 | |
Histology [n]a | Glioblastoma | 28 | 0 | 0 | 28 | 55 | 0 | 0 | 55 |
Astrocytoma | 10 | 4 | 4 | 2 | 1 | 0 | 0 | 1 | |
Astrocytoma wildtype | 3 | 0 | 3 | 0 | 2 | 0 | 2 | 0 | |
Oligodendroglioma | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
IDH & 1p19q codeletion status [n] | IDH-wildtype | 31 | 0 | 3 | 28 | 57 | 0 | 2 | 55 |
IDH-mutant, non-codeleted | 10 | 4 | 4 | 2 | 1 | 0 | 0 | 1 | |
IDH-mutant, codeleted | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
Vital status [n] | Deceased | 38 | 4 | 6 | 28 | 53 | 0 | 1 | 52 |
Alive | 5 | 2 | 1 | 2 | 5 | 0 | 1 | 4 | |
Days to recurrence | Median | 730.0 | 1414.5 | 1338.0 | 563.0 | 243.0 | n/a | 289.0 | 243.0 |
IQR | 669.5 | 813.3 | 760.5 | 471.0 | 152.0 | n/a | 46.0 | 152.0 | |
Age [yr] | Median | 49.0 | 41.5 | 35.0 | 52.0 | 57.0 | n/a | 47.5 | 57.0 |
IQR | 19.5 | 16.5 | 14.0 | 17.5 | 15.0 | n/a | 3.5 | 15.3 | |
